miR-16-1-3p
miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis
13
p62 acts as an oncogene and is targeted by miR-124-3p in glioma
13
High expression of miR-222-3p in children with Mycoplasma pneumoniae pneumonia
8
Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer
11
Loss of miR 542 3p enhances IGFBP 1 expression in decidualizing human endometrial stromal cells
10
The inverted pattern of circulating miR-221-3p and miR-222-3p associated with isolated low HDL-C phenotype
9
MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells
15
miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16
12
NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression
14
MiR-142-3p Regulates Cardiovascular System during Zebrafish Development
11
<p>miR-1-3p suppresses the epithelial-mesenchymal transition property in renal cell cancer by downregulating Fibronectin 1</p>
15
miR-29b-3p regulated osteoblast differentiation via regulating IGF-1 secretion of mechanically stimulated osteocytes
11
Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer
13
Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p
14
MiR-369-3p participates in endometrioid adenocarcinoma via the regulation of autophagy
10
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1
15
<p>MiR-124-3p.1 Sensitizes Ovarian Cancer Cells to Mitochondrial Apoptosis Induced by Carboplatin</p>
12
Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas
15
Methylation-mediated silencing of miR-133a-3p promotes breast cancer cell migration and stemness via miR-133a-3p/MAML1/DNMT3A positive feedback loop
20
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2
12